Organon & Co. OGN 深 沪
已收盘 08-07 16:00:00 美东时间
13.60
+0.050
+0.37%
华盛通- 最 高13.61
- 今 开13.57
- 成交量 333.26万股
- 最 低 13.55
- 昨 收 13.55
- 总市值 35.71亿
- 52周最高 13.61
- 市盈率 静 18.97
- 换手率 0.00%
- 52周最低 5.67
- 委 比 98.78%
- 总股本 2.63亿
- 历史最高 36.015
- 量 比 1.63
- 振 幅 0.44%
- 历史最低 5.67
- 每 手 1
- 风险率 2.66%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多财报速睇 | Organon & Co. 2026财年Q2营收15.57亿美元，同比下降2.4%；归母净利润1.08亿美元，同比下滑25.5%
华盛资讯7月31日讯，Organon & Co.公布2026财年Q2业绩，公司Q2营收15.57亿美元，同比下降2.4%，归母净利润1.08亿美元，同比下滑25.5%。
07-31 20:32
These mid-cap stocks combine A-rated profitability with attractive forward valuations
As the market moves through second-quarter earnings season, investors are paying close attention to mid-cap stocks that combine solid profitability with attractive valuations. Forward price-to-earnin...
07-27 21:59
ORGANON CANADA ANNOUNCES THE APPOINTMENT OF DOMINIC BÉGIN AS PRESIDENT AND MANAGING DIRECTOR
25-year industry leader to drive continued growth and expand access to medicines in Canada KIRKLAND, QC, July 22, 2026 /CNW/ -- Organon Canada, a global healthcare company dedicated to impro...
07-22 20:02
Organon Issues Supplemental Disclosures on Sun Pharma Merger
Organon ( ($OGN) ) has issued an announcement. On April 26, 2026, Organon agree...
07-18 05:38
Organon To Present Phase 3 Data Of VTAMA Cream In Atopic Dermatitis At 2026 Society For Pediatric Dermatology Annual Meeting
Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, today announced that a new analysis of Phase 3 data evaluating VTAMA cream in AD will be presented at the 2026 Society for Pediatric Dermatology (SPD) Annual Meetin...
07-07 20:01
欧加农获得无激素铜宫内节育器MIUDELLA的女性健康市场独家经营权
欧加农（Organon & Co.，股票代码：OGN）达成两项业务合作：一是与塞贝拉制药（Sebela Pharmaceuticals）签署无激素铜宫内...
06-30 21:27
Record-setting healthcare M&A activity to extend through H2: PwC
Healthcare dealmaking is already at the highest level since the pandemic, and the momentum is expected to continue into H2 2026, driven by looming patent cliffs and consumer demand for areas such as w...
06-26 01:59
复宏汉霖两款地舒单抗产品在加拿大商业化上市，携手Organon提升区域骨健康治疗...
内容来源：复宏汉霖 中国上海和加拿大魁北克省柯克兰市，2025年6月23日——复宏汉霖与Organon加拿大今日宣布，地舒单抗注射液（60 mg/mL）BI...
06-24 19:25
Organon and Henlius launch Prolia and Xgeva biosimilars in Canada
Organon Canada (OGN) and Shanghai Henlius Biotech on Tuesday announced the Canadian launch of Bildyos (denosumab injection) and Tuzemty (denosumab injection), biosimilars to Prolia and Xgeva, respecti...
06-23 18:28
